A 21-day Schedule of Gemcitabine and Cisplatin Administration in the Treatment of Advanced Non-Small Cell Lung Carcinoma: a Phase II Study

Jong Sung Park,Chang-Min Lee,Shin-Ae Lee,Chang-kil Jung,Sung Hyun Kim,Hyuk-Chan Kwon,Jae-Seok Kim,Hyo Jin Kim

A 21-day Schedule of Gemcitabine and Cisplatin Administration in the Treatment of Advanced Non-Small Cell Lung Carcinoma: a Phase II Study

2004

Jong Sung Park
Chang-Min Lee
Shin-Ae Lee
Chang-kil Jung
Sung Hyun Kim
Hyuk-Chan Kwon
Jae-Seok Kim
Hyo Jin Kim

Purpose To evaluate the efficacy and toxicity of gemcitabine and cisplatin combination chemotherapy, we conducted a phase II study of this regimen in patients with advanced non-small cell lung carcinoma (NSCLC).

Keywords:

Regimen
Pathology
Carcinoma
Cisplatin
Phases of clinical research
Small Cell Lung Carcinoma
Gemcitabine
Oncology
Toxicity
Internal medicine
Medicine
Chemotherapy
Lung
combination chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations